The U.S. Food and Drug Administration has approved the abbreviated new drug application for once-daily bromfenac ophthalmic solution 0.09%, according to a press release from Hi-Tech Pharmacal. Bromfenac is used to treat inflammation and ocular pain after cataract surgery. Hi-Tech plans to immediately launch the generic drug.
Recent study results showed greater improvement in Graves’ orbitopathy with the use of radioiodine ablation of post-thyroidectomy remnants after treatment with recombinant human serum thyrotropin.“Our results indicate that postoperative radioiodine ablation is more effective than thyroidectomy alone in inducing earlier and steadier [Graves’ orbitopathy] improvement,” Mariacarla Moleti, MD, PhD, of the department of clinical and experimental medicine, section of endocrinology, at the University of Messina, Italy, and colleagues wrote.
A comparative long-range study by Mayo Clinic ophthalmology researchers shows that the probability of blindness from glaucoma 20 years after diagnosis has dropped by half in the last generation. The findings appear online in the “in press” section of t…
The Harvard Medical School (HMS) Department of Ophthalmology has been granted a $250,000 Research to Prevent Blindness (RPB) Career Development Award to support eye research conducted by Jason I. Comander, M.D., Ph.D. The support will be provided over …
KOLOA, Hawaii — “Management of the Ocular Surface,” in two parts, and a mini symposium on neuro-ophthalmology top Thursday’s Hawaiian Eye Comprehensive Ophthalmology program. Moderators Michael B. Raizman, MD, and Terrence P. O’Brien, MD, share moderator duties for the ocular surface program; Andrew G. Lee, MD, moderates the symposium. Retina will feature a “Vitreous Surgery Symposium” and “Pediatric Retina Update: Intraocular Tumors.” Elias Reichel, MD, heads up both the symposium and the update.
KOLOA, Hawaii — When a sputum test is negative but there is a high degree of suspicion that a patient has tuberculosis, a decision whether to treat the disease needs to be made, a speaker said here. Sharing from his own experiences, Thomas A. Albini, MD, said at Retina 2014, “There’s no easy way to make these types of treatment decisions except for familiarity with these types of disease.” For suspected tuberculosis, physicians should be more concerned about people from endemic areas or those more likely to be exposed, such (Read more...)